Cancer treatment breakthrough? gentler steroid dose fights dangerous liver side effect
NCT ID NCT07167251
Summary
This study is testing if a lower, gentler dose of steroids can safely treat liver inflammation that sometimes occurs as a side effect of powerful cancer immunotherapies. It will involve about 63 adult cancer patients who develop this specific liver issue. The goal is to see if the lower dose works just as well as higher doses, which can cause more side effects and might weaken the cancer-fighting power of the immunotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Royal Marsden Hospital
NOT_YET_RECRUITINGLondon, SW3 6JJ, United Kingdom
-
University Hospital Basel
RECRUITINGBasel, Canton of Basel-City, 4031, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.